News - Zhongshan Wanhan Pharmaceuticals Co., Ltd

Wanhan Pharmaceuticals丨2024 Zhongshan Cuiheng Island Marathon: Striving for Excellence and Pushing Forward.
Wanhan Pharmaceuticals丨Congratulations on the successful approval of 2% and 5% Minoxidil Topical Solution.
Wanhan Pharmaceuticals丨Hydrobromide Vortioxetine API has been authorized.
Wanhan Pharmaceuticals丨Statement regarding the employment status of our sales staff.
Wanhan Pharmaceuticals丨Bromfenac Sodium API has successfully upgraded to Class A.